RESULTS	At 1 year , the primary efficacy end point of target-lesion revascularization occurred in 65 patients ( 4.3 % ) in the EES group and in 76 patients ( 5.0 % ) in the SES group , demonstrating noninferiority of EES to SES ( P ( noninferiority ) < 0.0001 , and P ( superiority ) = 0.34 ) .\